Braster S.A. (BRA) - Net Assets

Latest as of March 2024: zł-5.04 Million PLN ≈ $-1.39 Million USD

Based on the latest financial reports, Braster S.A. (BRA) has net assets worth zł-5.04 Million PLN (≈ $-1.39 Million USD) as of March 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł18.64 Million ≈ $5.13 Million USD) and total liabilities (zł23.68 Million ≈ $6.52 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Braster S.A. (BRA) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	zł-5.04 Million
% of Total Assets	-27.07%
Annual Growth Rate	N/A
5-Year Change	-121.31%
10-Year Change	-150.26%
Growth Volatility	3743.41

Braster S.A. - Net Assets Trend (2011–2023)

This chart illustrates how Braster S.A.'s net assets have evolved over time, based on quarterly financial data. Also explore how large is Braster S.A.'s balance sheet for the complete picture of this company's asset base.

Annual Net Assets for Braster S.A. (2011–2023)

The table below shows the annual net assets of Braster S.A. from 2011 to 2023. For live valuation and market cap data, see BRA market cap.

Year	Net Assets	Change
2023-12-31	zł-4.43 Million ≈ $-1.22 Million	-781.38%
2022-12-31	zł650.00K ≈ $178.89K	-63.17%
2021-12-31	zł1.76 Million ≈ $485.75K	-77.67%
2020-12-31	zł7.90 Million ≈ $2.18 Million	-61.98%
2019-12-31	zł20.79 Million ≈ $5.72 Million	-28.36%
2018-12-31	zł29.02 Million ≈ $7.99 Million	-40.54%
2017-12-31	zł48.80 Million ≈ $13.43 Million	+40.06%
2016-12-31	zł34.84 Million ≈ $9.59 Million	-17.05%
2015-12-31	zł42.00 Million ≈ $11.56 Million	+376.61%
2014-12-31	zł8.81 Million ≈ $2.43 Million	+48.83%
2013-12-31	zł5.92 Million ≈ $1.63 Million	-31.47%
2012-12-31	zł8.64 Million ≈ $2.38 Million	+13456.63%
2011-12-31	zł63.73K ≈ $17.54K	--

Equity Component Analysis

This analysis shows how different components contribute to Braster S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 12083822800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2023)

Component	Amount	Percentage
Common Stock	zł2.94 Million	%
Other Components	zł114.74 Million	%
Total Equity	zł-4.43 Million	100.00%

Braster S.A. Competitors by Market Cap

The table below lists competitors of Braster S.A. ranked by their market capitalization.

Company	Market Cap
Erika Carmel Ltd TA:BCUR	$4.69 Million
Riedel Resources Ltd AU:RIE	$4.69 Million
AS Rigas kugu buvetava STU:UW3	$4.69 Million
Sentral Mitra Informatika Tbk PT JK:LUCK	$4.70 Million
MAST ENERGY DEV. LS -001 F:97D	$4.69 Million
Xcel Brands Inc NASDAQ:XELB	$4.69 Million
Metals Creek Resources Corp V:MEK	$4.69 Million
Megaron SA WAR:MEG	$4.68 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Braster S.A.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2022 to 2023, total equity changed from 650,000 to -4,429,000, a change of -5,079,000 (-781.4%).
Net loss of 4,748,000 reduced equity.
Other comprehensive income decreased equity by 2,516,000.
Other factors increased equity by 2,185,000.

Equity Change Factors (2022 to 2023)

Factor	Impact	Contribution
Net Income	zł-4.75 Million	-107.2%
Other Comprehensive Income	zł-2.52 Million	-56.81%
Other Changes	zł2.19 Million	+49.33%
Total Change	zł-	-781.38%

Book Value vs Market Value Analysis

This analysis compares Braster S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2011-12-31	zł0.03	zł0.58	x
2012-12-31	zł3.49	zł0.58	x
2013-12-31	zł2.37	zł0.58	x
2014-12-31	zł2.10	zł0.58	x
2015-12-31	zł7.48	zł0.58	x
2016-12-31	zł5.65	zł0.58	x
2017-12-31	zł5.32	zł0.58	x
2018-12-31	zł3.16	zł0.58	x
2019-12-31	zł1.09	zł0.58	x
2020-12-31	zł0.32	zł0.58	x
2021-12-31	zł0.07	zł0.58	x
2022-12-31	zł0.02	zł0.58	x
2023-12-31	zł-0.15	zł0.58	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Braster S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -1488.40%
• Asset Turnover: 0.02x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-165.49%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	-479.08%	0.00%	0.00x	11.93x	zł-311.68K
2012	-18.71%	0.00%	0.00x	1.04x	zł-2.48 Million
2013	-50.98%	0.00%	0.00x	1.07x	zł-3.61 Million
2014	-38.62%	0.00%	0.00x	1.55x	zł-4.28 Million
2015	-9.56%	0.00%	0.00x	1.13x	zł-8.21 Million
2016	-41.30%	-3369.56%	0.01x	1.86x	zł-17.87 Million
2017	-51.01%	-6270.03%	0.01x	1.51x	zł-29.77 Million
2018	-68.18%	-2284.30%	0.02x	1.88x	zł-22.68 Million
2019	-74.74%	-2665.01%	0.01x	2.35x	zł-17.62 Million
2020	-202.32%	-8371.20%	0.01x	4.54x	zł-16.78 Million
2021	-515.86%	-2088.30%	0.02x	13.45x	zł-9.28 Million
2022	-601.08%	-174.42%	0.09x	37.39x	zł-3.97 Million
2023	0.00%	-1488.40%	0.02x	0.00x	zł-4.31 Million

Industry Comparison

This section compares Braster S.A.'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $20,198,630
Average return on equity (ROE) among peers: -26.24%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Braster S.A. (BRA)	zł-5.04 Million	-479.08%	N/A	$4.69 Million
Adiuvo Investment SA (ADV)	$29.00 Million	-44.86%	1.45x	$2.03 Million
Genomtec S.A. (GMT)	$7.57 Million	-144.47%	0.24x	$19.90 Million
Medinice S.A (ICE)	$3.26 Million	-15.53%	0.50x	$148.26 Million
Medicalg (MDG)	$2.83 Million	67.51%	0.30x	$72.31 Million
Synektik S.A. (SNT)	$58.33 Million	6.18%	0.83x	$674.16 Million

About Braster S.A.

WAR:BRA Poland Medical Devices

Market Cap

$4.69 Million

zł17.04 Million PLN

Market Cap Rank

#28487 Global

#327 in Poland

Share Price

zł0.58

Change (1 day)

+0.00%

52-Week Range

zł0.58 - zł0.58

All Time High

zł28.50